Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders

Bibliographic Details
Main Authors: A. Bayas, A. Berthele, B. Hemmer, C. Warnke, B. Wildemann
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Neurological Research and Practice
Online Access:https://doi.org/10.1186/s42466-021-00139-8
id doaj-b9c037afeb504331a889aa53da9d70aa
record_format Article
spelling doaj-b9c037afeb504331a889aa53da9d70aa2021-08-08T11:06:53ZengBMCNeurological Research and Practice2524-34892021-08-01311710.1186/s42466-021-00139-8Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disordersA. Bayas0A. Berthele1B. Hemmer2C. Warnke3B. Wildemann4Universitätsklinikum Augsburg, Klinik für Neurologie und klinische NeurophysiologieTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Klinik für NeurologieTechnische Universität München, Fakultät für Medizin, Klinikum rechts der Isar, Klinik für NeurologieKlinik und Poliklinik für Neurologie, Medizinische Fakultät, Universitätsklinik KölnNeurologische Klinik, Universitätsklinikum Heidelberghttps://doi.org/10.1186/s42466-021-00139-8
collection DOAJ
language English
format Article
sources DOAJ
author A. Bayas
A. Berthele
B. Hemmer
C. Warnke
B. Wildemann
spellingShingle A. Bayas
A. Berthele
B. Hemmer
C. Warnke
B. Wildemann
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
Neurological Research and Practice
author_facet A. Bayas
A. Berthele
B. Hemmer
C. Warnke
B. Wildemann
author_sort A. Bayas
title Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
title_short Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
title_full Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
title_fullStr Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
title_full_unstemmed Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
title_sort controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 dgn guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and mog-igg-associated disorders
publisher BMC
series Neurological Research and Practice
issn 2524-3489
publishDate 2021-08-01
url https://doi.org/10.1186/s42466-021-00139-8
work_keys_str_mv AT abayas controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders
AT aberthele controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders
AT bhemmer controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders
AT cwarnke controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders
AT bwildemann controversyonthetreatmentofmultiplesclerosisandrelateddisorderspositionalstatementoftheexpertpanelinchargeofthe2021dgnguidelineondiagnosisandtreatmentofmultiplesclerosisneuromyelitisopticaspectrumdiseasesandmogiggassociateddisorders
_version_ 1721216313019334656